| 2026-03-31 |
详情>>
内部人交易：
Chalke Sandeep股份减少40000.00股
|
| 2026-02-17 |
详情>>
股本变动：
变动后总股本11878.26万股
|
| 2026-02-17 |
详情>>
业绩披露：
2025年年报每股收益-0.02美元,归母净利润-159.1万美元,同比去年增长89.77%
|
| 2026-02-17 |
详情>>
业绩披露：
2026年一季报每股收益-0.18美元,归母净利润-2167.8万美元,同比去年增长-448.25%
|
| 2026-02-17 |
详情>>
业绩披露：
2026年中报每股收益-0.3美元,归母净利润-3544.8万美元,同比去年增长-2401.62%
|
| 2026-02-04 |
财报披露：
美东时间 2026-02-04 盘后发布财报
|
| 2025-10-01 |
股东大会：
将于2025-11-13召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors named in the proxy statement to hold office until our 2028 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified;
2.To approve our 2026 Equity Incentive Plan;
3.To conduct an advisory vote to approve the compensation of our named executive officers;
4.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2026;
5.To transact any other business as may properly come before the Annual Meeting, including any motion to adjourn to a later date to permit further solicitation of proxies, if necessary, or any adjournment or postponement of the meeting.
|
| 2025-05-02 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.03美元,归母净利润-271.4万美元,同比去年增长85.66%
|
| 2025-02-05 |
详情>>
业绩披露：
2025年中报每股收益-0.01美元,归母净利润-141.7万美元,同比去年增长88.75%
|
| 2024-11-06 |
详情>>
业绩披露：
2024年一季报每股收益-0.03美元,归母净利润-296.9万美元,同比去年增长45.51%
|
| 2024-11-06 |
详情>>
业绩披露：
2025年一季报每股收益-0.04美元,归母净利润-395.4万美元,同比去年增长-33.18%
|
| 2024-10-04 |
股东大会：
将于2024-11-21召开股东大会
会议内容 ▼▲
- 1.To elect two Class III directors named in the proxy statement to hold office until our 2027 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified;
2.To approve an amendment to our 2016 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance under such plan;
3.To approve an amendment to our 2007 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance under such plan;
4.To conduct an advisory vote to approve the compensation of our named executive officers;
5.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2025;
6.To transact any other business as may properly come before the Annual Meeting, including any motion to adjourn to a later date to permit further solicitation of proxies, if necessary, or any adjournment or postponement of the meeting.
|
| 2024-09-19 |
详情>>
业绩披露：
2024年年报每股收益-0.16美元,归母净利润-1554.5万美元,同比去年增长-67.51%
|
| 2024-09-19 |
详情>>
业绩披露：
2023年年报每股收益-0.1美元,归母净利润-928万美元,同比去年增长-73.56%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.19美元,归母净利润-1893.2万美元,同比去年增长-181.56%
|
| 2024-02-07 |
详情>>
业绩披露：
2024年中报每股收益-0.13美元,归母净利润-1259万美元,同比去年增长-71.92%
|
| 2023-09-29 |
股东大会：
将于2023-11-09召开股东大会
会议内容 ▼▲
- 1.To elect three Class II directors named in the proxy statement to hold office until our 2026 Annual Meeting of Stockholders, or until their respective successors have been duly elected or appointed;
2.To approve an amendment to our 2016 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance under such plan;
3.To conduct an advisory vote to approve the compensation of our named executive officers;
4.To conduct an advisory vote on the frequency of future advisory votes to approve the compensation of our named executive officers;
5.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2024;
6.To transact any other business as may properly come before the Annual Meeting, including any motion to adjourn to a later date to permit further solicitation of proxies, if necessary, or any adjournment or postponement of the meeting.
|
| 2022-09-30 |
股东大会：
将于2022-11-10召开股东大会
会议内容 ▼▲
- 1.To elect two Class I directors named in the proxy statement to hold office until our 2025 Annual Meeting of Stockholders, or until their respective successors have been duly elected or appointed;
2.To approve an amendment to our 2016 Equity Incentive Plan;
3.To approve an amendment to our 2007 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance under such plan;
4.To conduct an advisory vote to approve the compensation of our named executive officers;
5.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2023;
6.To transact any other business as may properly come before the Annual Meeting, including any motion to adjourn to a later date to permit further solicitation of proxies, if necessary, or any adjournment or postponement of the meeting.
|
| 2021-10-29 |
复牌提示：
2021-10-29 10:25:49 停牌，复牌日期 2021-10-29 10:30:49
|
| 2021-10-01 |
股东大会：
将于2021-11-19召开股东大会
会议内容 ▼▲
- 1.To elect three Class III directors named in the proxy statement to hold office until our 2024 Annual Meeting of Stockholders, or until their respective successors have been duly elected or appointed;
2.To conduct an advisory vote to approve the compensation of our named executive officers;
3.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2022;
4.To transact any other business as may properly come before the Annual Meeting, including any motion to adjourn to a later date to permit further solicitation of proxies, if necessary, or any adjournment or postponement of the meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-10-01 |
股东大会：
将于2020-11-20召开股东大会
会议内容 ▼▲
- 1.To elect two Class II directors named in the proxy statement to hold office until our 2023 Annual Meeting of Stockholders, or until their respective successors have been duly elected or appointed;
2.To approve an amendment to our 2016 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance under such plan;
3.To approve an amendment to our 2007 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance under such plan;
4.Advisory vote to approve the compensation of our named executive officers;
5.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2021;
6.To transact any other business as may properly come before the Annual Meeting, including any motion to adjourn to a later date to permit further solicitation of proxies, if necessary, or any adjournment or postponement of the meeting.
|
| 2019-10-03 |
股东大会：
将于2019-11-15召开股东大会
会议内容 ▼▲
- 1.To elect two Class I directors named in the proxy statement to hold office until our 2022 Annual Meeting of Stockholders, or until their respective successors have been duly elected or appointed;
2.Advisory vote to approve the compensation of our named executive officers;
3.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2020;
4.To transact any other business as may properly come before the Annual Meeting, including any motion to adjourn to a later date to permit further solicitation of proxies, if necessary, or any adjournment or postponement of the meeting.
|
| 2018-10-04 |
股东大会：
将于2018-11-16召开股东大会
会议内容 ▼▲
- 1.To elect two Class III directors named in the proxy statement to hold office until our 2021 Annual Meeting of Stockholders, or until their respective successors have been duly elected or appointed;
2.To approve an amendment to our 2016 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance under such plan;
3.To approve an amendment to our 2007 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for issuance under such plan;
4.Advisory vote to approve the compensation of our named executive officers;
5.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2019;
6.To transact any other business as may properly come before the Annual Meeting, including any motion to adjourn to a later date to permit further solicitation of proxies, if necessary, or any adjournment or postponement of the meeting.
|
| 2017-10-05 |
股东大会：
将于2017-11-17召开股东大会
会议内容 ▼▲
- 1.To elect three Class II directors named in the proxy statement to hold office until our 2020 Annual Meeting of Stockholders, or until their respective successors have been duly elected or appointed;
2.Advisory vote to approve the compensation of our named executive officers;
3.Advisory vote on the frequency of future advisory votes to approve the compensation of our named executive officers;
4.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2018;
5.To transact any other business as may properly come before the Annual Meeting, including any motion to adjourn to a later date to permit further solicitation of proxies, if necessary, or any adjournment or postponement of the meeting.
|
| 2016-10-07 |
股东大会：
将于2016-11-17召开股东大会
会议内容 ▼▲
- 1. To elect two Class I directors named in the proxy statement to hold office until our 2019 Annual Meeting of Stockholders, or until their respective successors have been duly elected or appointed;
2. To approve the Accuray Incorporated 2016 Equity Incentive Plan and the number of shares reserved for issuance thereunder;
3. To approve an amendment and restatement of the Accuray Incorporated 2007 Employee Stock Purchase Plan including, among other things, an increase in the number of shares of the Company's common stock available for issuance thereunder by 1,000,000 shares;
4. To re-approve the Company's Performance Bonus Plan;
5. Advisory vote to approve the compensation of our named executive officers;
6. To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2017;
7. To transact any other business as may properly come before the Annual Meeting, including any motion to adjourn to a later date to permit further solicitation of proxies, if necessary, or any adjournment or postponement of the meeting.
|